Two of the most popular recovery peptides, often stacked together. Here is how they compare.
| Attribute | BPC-157 Research use only | TB-500 Research use only |
|---|---|---|
| Class / type | Synthetic pentadecapeptide ('body protection compound') | Synthetic thymosin beta-4 fragment |
| How it works | Modulates angiogenesis via VEGFR2 and the Akt-eNOS/nitric-oxide axis; upregulates GH receptor in fibroblasts; anti-inflammatory and cytoprotective. | Sequesters G-actin to regulate actin dynamics and cell migration; supports stem/progenitor recruitment, angiogenesis, reduced inflammation. |
| Known / used for | Tendon/ligament/muscle/bone injury recovery; gut/GI protection; inflammation. Evidence is largely preclinical. | Wound/tendon/muscle/cardiac repair; corneal healing; recovery. Evidence is preclinical. |
| Positives | Consistent tissue-healing and gut-protective signals across many rodent models; widely reported anecdotal benefit for stubborn injuries. | Promising animal data across injury types; anecdotal soft-tissue recovery/flexibility; often stacked with BPC-157. |
| Negatives & risks | No published long-term human safety data and almost no controlled human trials. The main theoretical concern is how it heals: it partly works by helping the body grow new blood vessels (a process called angiogenesis) and by prompting cells to multiply and move. Tumors rely on those exact same processes to grow beyond a tiny size and to spread - so, in theory, the same signal that heals a tendon could also feed a cancer a person does not yet know they have. This is unproven in either direction, but it is the reason caution is urged for anyone with a personal or family history of cancer, or who is overdue for screening. Also: gray-market products vary in purity, and mild reported effects include nausea and headache. | No FDA-approved human use and only limited human data. Like BPC-157, it speeds repair partly by encouraging new blood-vessel growth and helping cells migrate into damaged tissue - and those are the very same processes a tumor uses to grow and to spread through the body. So there is a theoretical (unproven) worry that it could help an undiagnosed cancer along. This flag is taken a little more seriously for TB-500 because the natural protein it comes from (thymosin beta-4) has been linked to tumor progression in some studies. It is also banned in competitive sport (WADA), and gray-market purity is a real concern. |
| Legal status (Jul 2026) | NOT FDA-approved. Removed from Category 2 (Apr 2026); scheduled for FDA PCAC review Jul 23, 2026 - FDA's PROPOSED position is NOT to add it to the 503A list. Status in flux; verify. | NOT FDA-approved. Removed from Category 2 (Apr 2026); under PCAC review Jul 23, 2026 (FDA proposing NOT to list). Prohibited in sport. Verify. |